Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20
semaglutide use by date beyond A new study suggests GLP-1s could have a much greater impact Retatrutide is a new Libre Weekly Dose:0.5 mg
Retatrutide is a new weight-loss injection, which is currently in its final stages of safety and efficacy trials. UK approval is likely in 2027, pending full MHRA review. Developed by Eli Lilly
Regular exercise also increases the amount of calories your body burns, which can help you stay in a calorie deficit
Libre
Weekly Dose:0.5 mg
For the most up-to-date Mounjaro or Wegovy side effects, check your patient information leaflet
